Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$35,888
+$909 QoQ
Shares Held
229
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,457
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAYBAN holds $3,975,512 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,021 | $2,037,093 | |
| 2 | ABBV |
AbbVie Inc.
|
3,747 | $942,895 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,139 | $274,861 | |
| 4 | AMGN |
Amgen Inc
|
630 | $228,135 | |
| 5 | LLY |
ELI LILLY & Co
|
121 | $145,131 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
879 | $111,052 | |
| 7 | PFE |
Pfizer Inc
|
3,945 | $94,995 | |
| 8 | GSK |
GSK plc
|
1,273 | $66,730 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,888 | 229 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $34,979 | 229 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $24,127 | 175 | Shares | Sole | 2026-03-05 | |
| No filing history on record for this holder in this stock. | ||||||